Eileen O'Reilly, MD

Articles

Dr. O'Reilly on the Role of Germline Testing in Pancreatic Cancer

April 7th 2020

Eileen O'Reilly, MD, discusses germline testing in pancreatic cancer.

Dr. O'Reilly on Ongoing Trials With PARP Inhibitors in Pancreatic Cancer

February 22nd 2020

Eileen O'Reilly, MD, Winthrop Rockefeller Endowed Chair in Medical Oncology, co-director, Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer Research, section head, Hepatopancreaticobilary and Neuroendocrine Cancers, and medical oncologist, Memorial Sloan Kettering Cancer Center, discusses

Dr. O'Reilly on the Utility of PARP Inhibitors in Pancreatic Cancer

February 15th 2020

Eileen O'Reilly, MD, discusses the utility of PARP inhibitors in pancreatic cancer.

Dr. O'Reilly on Investigational Treatment Approaches in Pancreatic Cancer

December 18th 2019

Eileen O'Reilly, MD, associate director for clinical research and medical oncologist at Memorial Sloan Kettering Cancer Center, discusses investigational treatment approaches in advanced pancreatic cancer.

Dr. O'Reilly on the NEOLAP Study in Locally Advanced Pancreatic Cancer

October 11th 2019

Eileen O'Reilly, MD, discusses the phase II NEOLAP study which showed that more patients with locally advanced pancreatic cancer were able to undergo surgical resection following induction chemotherapy with gemcitabine and nab-paclitaxel or sequential FOLFIRINOX.

Dr. O'Reilly on Agents in Development in Advanced Pancreatic Cancer

October 8th 2019

Eileen O'Reilly, MD, associate director for clinical research and medical oncologist at Memorial Sloan Kettering Cancer Center, discusses agents in development in advanced pancreatic cancer.

Dr. O'Reilly on Immunotherapy in Pancreatic Cancer

June 22nd 2018

Eileen O'Reilly, MD, associate director for clinical research at Memorial Sloan Kettering Cancer Center, discusses the role of immunotherapy in the treatment of patients with pancreatic cancer.

Dr. O'Reilly Discusses Biomarker Research in Pancreatic Cancer

March 23rd 2018

Eileen O’Reilly, MD, associate director for clinical research at Memorial Sloan Kettering Cancer Center discusses biomarker research in pancreatic cancer.

Dr. O'Reilly on Areas of Research in Pancreatic Cancer

January 18th 2018

Eileen O’Reilly, MD, associate director for clinical research at Memorial Sloan Kettering Cancer Center discusses areas of research for patients with pancreatic cancer.

Dr. O'Reilly Discusses Advancements in Early-Stage Pancreatic Cancer

December 16th 2017

Eileen O’Reilly, MD, associate director for clinical research at Memorial Sloan Kettering Cancer Center, discusses advances for patients with early stage pancreatic cancer.

Dr. O'Reilly on Tarextumab Combinations for Metastatic Pancreatic Cancer

January 27th 2017

Eileen O’Reilly, MD, associate director for clinical research at Memorial Sloan Kettering Cancer Center, discusses tarextumab combinations for patients with pancreatic cancer.